Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2022 Earnings

27OctConfirmed

Q1 2022

Q2 2022

Q3 2022

Q4 2022

-14.36

-12.16

-9.97

-7.77

Details

Expected EPS

-9.557705

Actual EPS

-14.363255

Surprise EPS

-4.81

Surprise Percent

+50.28%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -14.363255 per share for Q4 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.